SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Logi who wrote (67)1/24/1997 3:29:00 AM
From: luis a. garcia   of 1115
 
Logi LIDAK was a recommendation for the month of Jan. It was added as a buy to the model portfolio at 1.75 (I believe) and is a play on the LIDAKOL phase 3 testing underway achieving succesful results this time around. (previous test used an active placebo inadvertently which spoiled the data). LIDAKOL passed Europenan equivalence test vs ZOVIRAK. Company is sitting on sizable cash...and insider bought 10k shares recently. tgt for high summer is around 6 or 7 bucks
based on where it previously traded the first time around ...no guaranties .. of course past is not prolog..

regards

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext